Division of Gastroenterology at University of Pennsylvania, Philadelphia, Pennsylvania.
Inflamm Bowel Dis. 2019 Jul 17;25(8):1302-1312. doi: 10.1093/ibd/izz021.
Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, can be effectively monitored with the use of endoscopy. The additional application of small field imaging technology such as confocal laser endomicroscopy CLE during ongoing endoscopic evaluation has led to real-time visualization of mucosal abnormalities and thus in vivo histology. The endomicroscopy (CLE) can improve IBD endoscopic evaluation by identifying seemingly normal-appearing mucosa, assessing the function of the intestinal barrier of the epithelium and vascular permeability, and by characterizing any mucosal lesions, including dysplastic lesions. CLE used during conventional endoscopy could especially facilitate the evaluation of mucosal healing in IBD. In addition, future developments in molecular imaging in IBD may optimize therapeutic approaches by identifying mucosal targets for therapy and determining the reasons for lack of response to specific therapy or subsequent loss of the response.
炎症性肠病(IBD),包括克罗恩病和溃疡性结肠炎,可以通过内镜检查进行有效监测。在持续的内镜评估中,额外应用共聚焦激光内镜检查(CLE)等小视野成像技术,可以实时可视化黏膜异常,从而实现体内组织学检查。内镜检查(CLE)可以通过识别看似正常的黏膜、评估上皮和血管通透性的肠屏障功能以及描述任何黏膜病变(包括发育异常病变)来改善 IBD 的内镜评估。在常规内镜检查中使用 CLE 可以特别有助于评估 IBD 中的黏膜愈合。此外,IBD 中分子成像的未来发展可能通过确定治疗的黏膜靶点和确定对特定治疗缺乏反应或随后失去反应的原因来优化治疗方法。